These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18005134)

  • 1. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.
    Bleich A; Sundberg JP; Smoczek A; von Wasielewski R; de Buhr MF; Janus LM; Julga G; Ukena SN; Hedrich HJ; Gunzer F
    Int J Exp Pathol; 2008 Feb; 89(1):45-54. PubMed ID: 18005134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
    Huang HC; Vlasova AN; Kumar A; Kandasamy S; Fischer DD; Deblais L; Paim FC; Langel SN; Alhamo MA; Rauf A; Shao L; Saif LJ; Rajashekara G
    Benef Microbes; 2018 Jan; 9(1):71-86. PubMed ID: 29022385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
    Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
    J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
    Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
    PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.
    Splichalova A; Trebichavsky I; Rada V; Vlkova E; Sonnenborn U; Splichal I
    Clin Exp Immunol; 2011 Feb; 163(2):242-9. PubMed ID: 21155989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and Neonatal Imprinting on Immunological Homeostasis and Epithelial Barrier Integrity by
    Sarate PJ; Srutkova D; Geissler N; Schwarzer M; Schabussova I; Inic-Kanada A; Kozakova H; Wiedermann U
    Front Immunol; 2020; 11():612775. PubMed ID: 33679699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.
    Gronbach K; Eberle U; Müller M; Olschläger TA; Dobrindt U; Leithäuser F; Niess JH; Döring G; Reimann J; Autenrieth IB; Frick JS
    Infect Immun; 2010 Jul; 78(7):3036-46. PubMed ID: 20421387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.
    Sabharwal H; Cichon C; Ölschläger TA; Sonnenborn U; Schmidt MA
    Infect Immun; 2016 Sep; 84(9):2482-92. PubMed ID: 27297392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
    Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
    Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.
    Schultz M; Strauch UG; Linde HJ; Watzl S; Obermeier F; Göttl C; Dunger N; Grunwald N; Schölmerich J; Rath HC
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):372-8. PubMed ID: 15013990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization.
    Barth S; Duncker S; Hempe J; Breves G; Baljer G; Bauerfeind R
    J Appl Microbiol; 2009 Nov; 107(5):1697-710. PubMed ID: 19457029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917.
    Toloza L; Giménez R; Fábrega MJ; Alvarez CS; Aguilera L; Cañas MA; Martín-Venegas R; Badia J; Baldomà L
    BMC Microbiol; 2015 Oct; 15():250. PubMed ID: 26518156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic
    Kim D; Kim Y; Yoon SH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672760
    [No Abstract]   [Full Text] [Related]  

  • 15. Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917.
    Massip C; Branchu P; Bossuet-Greif N; Chagneau CV; Gaillard D; Martin P; Boury M; Sécher T; Dubois D; Nougayrède JP; Oswald E
    PLoS Pathog; 2019 Sep; 15(9):e1008029. PubMed ID: 31545853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Mobility Group Box 1 and TLR4 Signaling Pathway in Gnotobiotic Piglets Colonized/Infected with
    Splichal I; Donovan SM; Jenistova V; Splichalova I; Salmonova H; Vlkova E; Neuzil Bunesova V; Sinkora M; Killer J; Skrivanova E; Splichalova A
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
    Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic
    Dusek O; Fajstova A; Klimova A; Svozilkova P; Hrncir T; Kverka M; Coufal S; Slemin J; Tlaskalova-Hogenova H; Forrester JV; Heissigerova J
    Cells; 2020 Dec; 10(1):. PubMed ID: 33375578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
    Raghuvanshi R; Chaudhari A; Kumar GN
    Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.